Chinese Journal of New Drugs - Digital Cluster of Scitech Periodicals

Home>Journals>Chinese Journal of New Drugs

Chinese Journal of New Drugs

CSCD

ISTIC

PKU

ISSN：1003-3734

CN：11-2850/R

Frequency：Semimonthly

Website：http://www.newdrug.cn

Email：bianjibu@newdrug.cn

Postcode：100098

Articles12737

Citations124451

Funded4496

Impact Factor：2.35

Official Website

Articles

2022 No.10

Total 16 articles

Aducanumab, the first Alzheimer's disease therapeutic drug targeting amyloid betaZHANG Fang, LIU Jie, SUN Tao-hua, CHEN An-jin, SHI Jie

929-932

The visible particles or insoluble particles in antibody drug formulationsJIA Dong-chen, HE Wu

933-936

The control strategy of starting materials used in solid-phase peptide synthesisWU Yi-fan, LIU Fu-li

937-941

Prediction of the disintegration time limit of olanzapine orally disintegrating tablets based on the physical fingerprint of crospovidone and its critical quality attributesWANG Jue, HU Li, YANG Rui, SUN Hui-min

942-949

The stability of group A&C meningococcal and Haemophilus influenzae type b ( conjugate) combined vaccineMU Shan-shan, WANG Zhen-ye, JIANG Zhi-yi, CHEN Zhong-wei, LIU Xiao-lei, SUN Shu-xue

950-954

A review on the application of electrohydrodynamic technology in nano drug loading systemSUN Chu-jun, LI Meng-hao, LIU Lei, WANG Xiao-hui, DU Qing

955-964

Progress in application of electrospray technology in preparation of microparticlesLI Yuan-qing, ZHAO Feng, MA Yin-ling, LIU Hong-xing, YIN Dian-shu

965-971

Implementation and management of drug clinical trials during the period of COVID-19 epidemicLU Ming-ying, LIU Yu, LIU Qing-yue, YI Qiu-yue, ZHANG Cai-xia, LIU Xia, ZHANG Ya-ni

972-977

Practice and reflection on the informatization of ethics reviewWANG Hui, WU Da-wei, YAN Zhao, TANG Qi-yu, LI Zi-wei, LI Ya-nan, XU Zhen-gang, TANG Yu, LI Ning

978-982

Management of bioequivalence trials for orally inhaled and nasal drug productsWANG Xiao-qian, LIU Hong-jiao, LIU Chuan, CHEN Xi-jing

983-990